© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 8, 583-596,
April 18, 2001
© 2001 Oxford University Press
SPECIAL ARTICLE |
Guidelines 2000 for Colon and Rectal Cancer Surgery
Affiliations of authors: H. Nelson, D. Sargent, Mayo Clinic, Rochester, MN; N. Petrelli, Roswell Park Cancer Institute, Buffalo, NY; A. Carlin, Wayne State University, Detroit, MI; J. Couture, Mount Sinai Hospital, Toronto, ON, Canada; J. Fleshman, Barnes-Jewish Hospital, St. Louis, MO; J. Guillem, Memorial Sloan-Kettering Cancer Center, New York, NY; B. Miedema, University of Missouri, Columbia; D. Ota, Ellis Fischel Cancer Center, Columbia, MO. (These authors make up the Writing Committee on behalf of the Expert Panel. All members of the Expert Panel and their institutional and Cancer Cooperative Group affiliations are listed in "Appendix 1.")
Correspondence to: Heidi Nelson, M.D., Mayo Clinic, 200 First St., S.W., Rochester, MN 55905 (e-mail: nelsonh{at}mayo.edu).
Background: Oncologic resection techniques affect outcome for colon cancer and rectal cancer, but standardized guidelines have not been adopted. The National Cancer Institute sponsored a panel of experts to systematically review current literature and to draft guidelines that provide uniform definitions, principles, and practices. Methods: Methods were similar to those described by the American Society of Clinical Oncology in developing practice guidelines. Experts representing oncology and surgery met to review current literature on oncologic resection techniques for level of evidence (I–V, where I is the best evidence and V is the least compelling) and grade of recommendation (A–D, where A is based on the best evidence and D is based on the weakest evidence). Initial guidelines were drafted, reviewed, and accepted by consensus. Results: For the following seven factors, the level of evidence was II, III, or IV, and the findings were generally consistent (grade B): anatomic definition of colon versus rectum, tumor–node–metastasis staging, radial margins, adjuvant R0 stage, inadvertent rectal perforation, distal and proximal rectal margins, and en bloc resection of adherent tumors. For another seven factors, the level of evidence was II, III, or IV, but findings were inconsistent (grade C): laparoscopic colectomy; colon lymphadenectomy; level of proximal vessel ligation, mesorectal excision, and extended lateral pelvic lymph node dissection (all three for rectal cancer); no-touch technique; and bowel washout. For the other four factors, there was little or no systematic empirical evidence (grade D): abdominal exploration, oophorectomy, extent of colon resection, and total length of rectum resected. Conclusions: The panel reports surgical guidelines and definitions based on the best available evidence. The availability of more standardized information in the future should allow for more grade A recommendations.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. S. Kukreja, E. Esteban-Agusti, J. M. Velasco, and T. J. Hieken Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease? Arch Surg, July 1, 2009; 144(7): 612 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M Bertagnolli Doing our best: surgery for rectal cancer Gut, December 1, 2008; 57(12): 1643 - 1645. [Full Text] [PDF]
|
|
|
|
|
|
F. C. Wright, A. R. Gagliardi, C. H. L. Law, L. D. Last, A. E. Klevan, S. Hongjinda, L. W. Stitt, N. Klar, D. P. Ryan, and A. J. Smith A Randomized Controlled Trial to Improve Lymph Node Assessment in Stage II Colon Cancer Arch Surg, November 1, 2008; 143(11): 1050 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Bilimoria, D. J. Bentrem, A. K. Stewart, M. S. Talamonti, D. P. Winchester, T. R. Russell, and C. Y. Ko Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report Card J Natl Cancer Inst, September 17, 2008; 100(18): 1310 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Desch, K. K. McNiff, E. C. Schneider, D. Schrag, J. McClure, E. Lepisto, M. S. Donaldson, K. L. Kahn, J. C. Weeks, C. Y. Ko, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures J. Clin. Oncol., July 20, 2008; 26(21): 3631 - 3637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Grote, A. H. Hughes, C. C. Rimmer, D. A. Less, A. P. Abernethy, and Multidisciplinary Gastrointestinal Tumor Board, De Targeting Lymph Node Retrieval and Assessment in Stage II Colon Cancer: A Quality Outcome Community-Based Cancer Center Study J. Oncol. Pract, March 1, 2008; 4(2): 55 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Boller and H. Nelson Colon and Rectal Cancer: Laparoscopic or Open? Clin. Cancer Res., November 15, 2007; 13(22): 6894s - 6896s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Tomlinson, S. Jain, D. J. Bentrem, E. G. Sekeris, M. A. Maggard, O. J. Hines, H. A. Reber, and C. Y. Ko Accuracy of Staging Node-Negative Pancreas Cancer: A Potential Quality Measure Arch Surg, August 1, 2007; 142(8): 767 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Greene, K. W. Kercher, H. Nelson, C. M. Teigland, and A.-M. Boller Minimal Access Cancer Management CA Cancer J Clin, May 1, 2007; 57(3): 130 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Chang, M. A. Rodriguez-Bigas, J. M. Skibber, and V. A. Moyer Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review J Natl Cancer Inst, March 21, 2007; 99(6): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Transatlantic Laparoscopically Assisted vs Open Co Laparoscopically Assisted vs Open Colectomy for Colon Cancer: A Meta-analysis Arch Surg, March 1, 2007; 142(3): 298 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lemmens, I van Lijnschoten, M. Janssen-Heijnen, H. Rutten, C. Verheij, and J-W. Coebergh Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study Ann. Onc., December 1, 2006; 17(12): 1803 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. McGory, P. G. Shekelle, and C. Y. Ko Development of Quality Indicators for Patients Undergoing Colorectal Cancer Surgery. J Natl Cancer Inst, November 15, 2006; 98(22): 1623 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Govindarajan, N. G. Coburn, A. Kiss, L. Rabeneck, A. J. Smith, and C. H. L. Law Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst, October 18, 2006; 98(20): 1474 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Johnson, G. A. Porter, R. Ricciardi, and N. N. Baxter Increasing Negative Lymph Node Count Is Independently Associated With Improved Long-Term Survival in Stage IIIB and IIIC Colon Cancer J. Clin. Oncol., August 1, 2006; 24(22): 3570 - 3575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Silva, E. A. Vens, A. K. Hara, J. G. Fletcher, J. L. Fidler, and C. D. Johnson Evaluation of Benign and Malignant Rectal Lesions with CT Colonography and Endoscopic Correlation. RadioGraphics, July 1, 2006; 26(4): 1085 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Benzoni, D Intersimone, G Terrosu, V Bresadola, A Cojutti, F Cerato, and C Avellini Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer J. Clin. Pathol., May 1, 2006; 59(5): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akasu, Y. Moriya, Y. Ohashi, S. Yoshida, K. Shirao, S. Kodaira, and for the National Surgical Adjuvant Study of Colore Adjuvant Chemotherapy with Uracil-Tegafur for Pathological Stage III Rectal Cancer after Mesorectal Excision with Selective Lateral Pelvic Lymphadenectomy: A Multicenter Randomized Controlled Trial Jpn. J. Clin. Oncol., April 1, 2006; 36(4): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zerey, J. M. Burns, K. W. Kercher, T. S. Kuwada, and B. T. Heniford Minimally Invasive Management of Colon Cancer Surgical Innovation, March 1, 2006; 13(1): 5 - 15. [Abstract] [PDF]
|
|
|
|
|
|
S Kurokawa, Y Arimura, H Yamamoto, Y Adachi, T Endo, T Sato, T Suga, M Hosokawa, Y Shinomura, and K Imai Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers Gut, December 1, 2005; 54(12): 1751 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Wong, D. S. Johnson, D. Hemmings, A. Hsu, T. Imai, and G. T. Tominaga Assessing the Quality of Colorectal Cancer Staging: Documenting the Process in Improving the Staging of Node-Negative Colorectal Cancer Arch Surg, September 1, 2005; 140(9): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fujie, H. Yamamoto, C. Y. Ngan, A. Takagi, T. Hayashi, R. Suzuki, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, et al. Oxaliplatin, a Potent Inhibitor of Survivin, Enhances Paclitaxel-induced Apoptosis and Mitotic Catastrophe in Colon Cancer Cells Jpn. J. Clin. Oncol., August 1, 2005; 35(8): 453 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Poplin, J. K. Benedetti, N. C. Estes, D. G. Haller, R. J. Mayer, R. M. Goldberg, G. R. Weiss, S. E. Rivkin, and J. S. Macdonald Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levamisole for Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer J. Clin. Oncol., March 20, 2005; 23(9): 1819 - 1825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Baxter, D. J. Virnig, D. A. Rothenberger, A. M. Morris, J. Jessurun, and B. A. Virnig Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based Study J Natl Cancer Inst, February 2, 2005; 97(3): 219 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akasu, G. Iinuma, T. Fujita, Y. Muramatsu, U. Tateishi, K. Miyakawa, T. Murakami, and N. Moriyama Thin-Section MRI with a Phased-Array Coil for Preoperative Evaluation of Pelvic Anatomy and Tumor Extent in Patients with Rectal Cancer Am. J. Roentgenol., February 1, 2005; 184(2): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Soumaoro, H. Uetake, T. Higuchi, Y. Takagi, M. Enomoto, and K. Sugihara Cyclooxygenase-2 Expression: A Significant Prognostic Indicator for Patients With Colorectal Cancer Clin. Cancer Res., December 15, 2004; 10(24): 8465 - 8471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. O'Connell, M. A. Maggard, and C. Y. Ko Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging J Natl Cancer Inst, October 6, 2004; 96(19): 1420 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K.F. Temple, L. Hsieh, W. D. Wong, L. Saltz, and D. Schrag Use of Surgery Among Elderly Patients With Stage IV Colorectal Cancer J. Clin. Oncol., September 1, 2004; 22(17): 3475 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Onate-Ocana, R. Montesdeoca, C. M. Lopez-Graniel, V. Aiello-Crocifoglio, R. Mondragon-Sanchez, M. Cortina-Borja, R. Herrera-Goepfert, C. Oros-Ovalle, and D. Gallardo-Rincon Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy Jpn. J. Clin. Oncol., June 1, 2004; 34(6): 323 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Greene, A. K. Stewart, and H. J. Norton New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Morris, K. G. Billingsley, N. N. Baxter, and L.-M. Baldwin Racial Disparities in Rectal Cancer Treatment: A Population-Based Analysis Arch Surg, February 1, 2004; 139(2): 151 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Mitchell Prognosis After Rectal Cancer Treatment in Blacks and Whites: Advanced Stage at Diagnosis or Other Factors? J. Clin. Oncol., February 1, 2003; 21(3): 397 - 398. [Full Text] [PDF]
|
|
|
|
|
|
S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, et al. Comparative Detection of Lymph Node Micrometastases of Stage II Colorectal Cancer by Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry J. Clin. Oncol., October 15, 2002; 20(20): 4232 - 4241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Rodriguez-Bigas Pathologic Evaluation of Total Mesorectal Excision: Big Brother Is Watching J. Clin. Oncol., April 1, 2002; 20(7): 1714 - 1715. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kaiser and N. Katkhouda Laparoscopic Management of the Perforated Viscus Surgical Innovation, March 1, 2002; 9(1): 46 - 53. [Abstract] [PDF]
|
|
|
|
|
|
S. Noura, H. Yamamoto, Y. Miyake, B. no Kim, O. Takayama, I. Seshimo, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, et al. Immunohistochemical Assessment of Localization and Frequency of Micrometastases in Lymph Nodes of Colorectal Cancer Clin. Cancer Res., March 1, 2002; 8(3): 759 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nelson and D. J. Sargent Refining Multimodal Therapy for Rectal Cancer N. Engl. J. Med., August 30, 2001; 345(9): 690 - 692. [Full Text] [PDF]
|
|